Project Grant R01DC021990
- This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the federal grant program "Research Related to Deafness and Communication Disorders" (CFDA 93.173), provides $633,694 to North Carolina State University to develop a non-invasive treatment strategy using a vocal fold lamina propria extract (VFLPX) to address vocal fold scarring and laryngotracheal injuries. The key objectives are to: 1) conduct detailed investigations...
- This $631,703 federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) aims to investigate the use of muscle progenitor (stem) cells for treating vocal fold paralysis. The research project, conducted by The Washington University, will test the effectiveness of implanting these cells into the laryngeal muscles of canine models to improve nerve recovery...
- The federal Project Grant award of $340,417 from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) will fund research to evaluate the clinical efficacy of local translaryngeal vibration therapy (LTLV) as a concurrent treatment approach with flow phonation voice therapy for patients with muscle tension dysphonia, a common voice disorder. The research aims to determine the optimal...
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to identify the electrophysiological characteristics of spinal motor neurons during the recovery stages following a spinal cord injury (SCI) in mouse models. The $470,293 award to the Research Foundation for the State University of New York (RF SUNY) at Binghamton will employ soft,...
- This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), will support research to investigate vocal dysfunction and vagally mediated brainstem pathology in the prodromal stage of Parkinson's disease. The $126,442 award to the University of Wisconsin - Madison will fund a study using a rat model with a PINK1 gene knockout to evaluate differences in vocal,...
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $411,941 to Drexel University to conduct research on identifying novel trunk reflex pathways and how they differ after neonatal versus adult spinal cord injury in animal models. The key objectives are to test the hypothesis that the newly discovered contralateral monosynaptic trunk...
- Renerva LLC, a for-profit manufacturer, is developing peripheral nerve matrix (PNM) technologies to facilitate functional recovery in animal models of direct muscle neurotization (DMN) through a $494,955 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853). The two-year project aims to 1) optimize the formulation of a clinical-grade PNM product to provide...
- This federal Project Grant award for $569,695.00, provided by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), supports research into the therapeutic potential of phrenic proprioceptors, or sensory neurons, to restore respiratory function after cervical spinal cord injury. The research, conducted by Marquette University, aims to test the hypothesis that activating these phrenic proprioceptors can induce spinal plasticity and improve breathing...
- This $142,074 federal Project Grant award is funded by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173). The grant supports research to investigate the inflammatory mechanisms and microbial factors contributing to acute laryngeal injury (ALGI) and glottic stenosis, which frequently occur following intubation and mechanical ventilation. The research aims to characterize the...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $652,497 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program to The General Hospital Corporation (Massachusetts General Hospital) for the project "Defining the Neurological Substrates of Proximal Upper Extremity Motor Control and Recovery After Stroke". The 5-year project aims to (1) determine baseline relationships between the...
CENTRAL MODULATION-PAIRED MOTOR REHABILITATION FOR RECURRENT LARYNGEAL NERVE INJURY - PROJECT SUMMARY/ABSTRACT RECURRENT LARYNGEAL NERVE (RLN) INJURY CAUSES VOCAL FOLD MOTION IMPAIRMENTS (E.G., VOCAL FOLD PARALYSIS). THE INABILITY TO ADDUCT (CLOSE) THE VOCAL FOLDS HAS CONSEQUENCES FOR AIRWAY PROTECTION DURING SWALLOWING (DEGLUTITION) AND VOCAL COMMUNICATION. THESE LARYNGEAL MOTOR DEFICITS RESULT IN INCREASED RISK OF ASPIRATION PNEUMONIA AND HAVE PROFOUND EFFECTS ON VOCAL COMMUNICATION REQUIRED FOR VOCATION, SAFETY, AND SOCIAL ENCOUNTERS. THE RESULT IS ALSO SIGNIFICANT ECONOMIC BURDEN, PSYCHOSOCIAL CONSEQUENCES, AND REDUCED QUALITY OF LIFE. CURRENT SURGICAL APPROACHES FOCUS ON MEDIALIZING THE VOCAL FOLDS TO IMPROVE GLOTTIC CLOSURE, BUT THEY DO LITTLE TO RESTORE FUNCTIONAL MOBILITY TO THE VOCAL FOLD MUSCLES WITHIN THE LARYNX. THE KEY ISSUE IS THAT CURRENT TREATMENTS RARELY RECOVER VOCAL FOLD MOVEMENT AFTER RLN INJURIES DUE TO NERVE SYNKINESIS AT THE PERIPHERY AND UPSTREAM CORTICOBULBAR SOMATO- TOPIC DISORGANIZATION AFTER SPONTANEOUS REINNERVATION. ONE SOLUTION IS TO REORGANIZE UPSTREAM MOTOR PATHWAYS IN THE CENTRAL NERVOUS SYSTEM TO IMPROVE DOWNSTREAM RESTORATION OF LARYNGEAL MUSCLE FUNCTION AFTER RLN INJURY. ELECTRICAL STIMULATION TO THE VAGUS NERVE HAS PREVIOUSLY BEEN SHOWN TO RELEASE NEUROMODULATORS IN THE BRAIN THAT EXCITE TASK-SPECIFIC NEURAL CIRCUITS AND DOWN-REGULATE LESS IMPORTANT CIRCUITS TO IMPROVE MOTOR INPUT TO THE FORELIMB AFTER MEDIAN-ULNAR NERVE INJURY IN A RAT FORELIMB INJURY MODEL. SIMILARLY, OUR PRELIMINARY DATA IN A RAT MODEL OF RIGHT RLN INJURY HAS SHOWN THAT TEMPORAL PAIRING OF ENHANCED CENTRAL NEUROMODULATION IN THE BRAIN WITH A MOTOR-SPECIFIC LARYNGEAL BEHAVIOR, LIKE DEGLUTITION, MAY ALSO RESTORE LARYNGEAL MOTOR FUNCTION. THE OBJECTIVE OF THIS PROPOSAL IS TO DETERMINE THE EFFECTS OF NEUROMODULATION-PAIRED DEGLUTITION ON RECOVERY OF LARYNGEAL MOTOR FUNCTION AND CENTRAL NEUROPLASTICITY IN A RAT MODEL OF RLN INJURY. CAPITALIZING ON OUR PROMISING PRELIMINARY DATA, ANIMALS WILL BE DIVIDED INTO ONE OF THREE GROUPS: ENHANCED NEUROMODULATION PAIRED WITH DEGLU- TITION, DEGLUTITION TRAINING ONLY, AND NEUROMODULATION ONLY. ENHANCED NEUROMODULATION OUTCOMES ACROSS ACUTE AND CHRONIC RLN INJURY WILL BE DETERMINED IN AIM 1 AND ACROSS IPSILATERAL AND CONTRALATERAL INJURY IN AIM 2. FUNC- TIONAL EFFECTS OF NEUROMODULATION/DEGLUTITION COMBINATIONS WILL BE EVALUATED USING LARYNGOSCOPY TO QUANTIFY VOCAL FOLD MOVEMENT ESSENTIAL FOR AIRWAY PROTECTION AND VOCALIZATION. WE WILL ALSO RECORD ULTRASONIC VOCALIZATIONS TO CHARACTERIZE CHANGES IN VOCAL INTENSITY AND TONALITY ACROSS THE GROUPS. CENTRAL NEUROPLASTIC EFFECTS WILL BE ELUCI- DATED WITH RETROGRADE TRACING AND SOMATOTOPIC CORTICOBULBAR MAPPING. EFFECTS OF IPSILATERAL SIMULATION ON THE RLN WILL ALSO BE ELUCIDATED IN AIM 2 USING LARYNGEAL MUSCLE NEUROMUSCULAR JUNCTION COUNT AND MORPHOLOGY ANALYSIS. EXPECTED OUTCOMES WILL BE KNOWN FUNCTIONAL AND MECHANISTIC EFFECTS OF NEUROMODULATION-PAIRED DEGLUTITION. RE- SULTS WILL PROVIDE A SPRINGBOARD FOR NOVEL TREATMENT APPROACHES FOR PATIENTS WITH RLN INJURY-INDUCED LARYNGEAL MOTOR IMPAIRMENTS (E.G., VOCAL FOLD PARALYSIS).
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $591.2k | 7/15/25 | ||
| Not listed | $618.0k | 7/31/24 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
24012010S | The University Of Texas Southwestern Medical Center | Project Grant R01DC021990 | $50.4k | 8/1/24 |